Imagen de Portada

Impact of accelerated biological aging and genetic variation on esophageal adenocarcinoma: Joint and interaction effect in a prospective cohort

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Renjia Zhao, Huangbo Yuan, Shuaizhou Chen, Kelin Xu, Tiejun Zhang, Zhenqiu Liu, Yanfeng Jiang, Chen Suo, Xingdong Chen
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	International Journal of Cancer
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Multilevel pathways to esophageal cancer: Population attributable risks of modifiable exposures, surrogate blood biomarkers, and genetic susceptibility, and the mediation effects based on a 10‐year prospective cohort study
por: Zixuan Cui, et al.
Publicado: (2026)

Steatotic Liver Disease Prevalence in China: A Population‐Based Study and Meta‐Analysis of 17.4 Million Individuals
por: Zhenqiu Liu, et al.
Publicado: (2025)

Changes of Helicobacter pylori Infection Status and Risk of Precancerous Lesions: A Prospective Cohort Study in Chinese Population
por: Xufei Xing, et al.
Publicado: (2026)

Association between prediagnostic serum metabolites and pancreatic ductal adenocarcinoma risk in two prospective cohorts
por: Ting Zhang, et al.
Publicado: (2025)

Family history and genetic risk score combined to guide cancer risk stratification: A prospective cohort study
por: Chen Ji, et al.
Publicado: (2024)

Single extracellular vesicle surface protein‐based blood assay identifies potential biomarkers for detection and screening of five cancers
por: Yuxin Min, et al.
Publicado: (2024)

Comment on “Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case‐cohort study”
por: Rui Wang, et al.
Publicado: (2024)

The variations in the natural history of high‐risk human papillomavirus infections in Chinese healthy women aged 27–45 years compared with 18–26 years: A prospective cohort study
por: Qi Chen, et al.
Publicado: (2024)

The impact of BTK knockdown on lung adenocarcinoma growth and immune response
por: Jilan Huang, et al.
Publicado: (2024)

The transcriptional landscape and clinico‐biological characterization of human endogenous retroviruses in esophageal squamous cell carcinoma
por: Xinrui Shi, et al.
Publicado: (2024)

Anti‐PD‐L1 antibody TQB2450 combined with tyrosine kinase receptor inhibitor AL2846 for immunotherapy‐refractory advanced hepatocellular carcinoma and esophageal squamous cell carcinoma: A prospective phase 1b cohort study
por: Tao Ning, et al.
Publicado: (2024)

Patient‐reported outcomes in NRG Oncology RTOG 1010: Phase 3 trial evaluating the addition of trastuzumab to trimodality treatment of HER2 overexpressing esophageal adenocarcinoma
por: Lisa A. Kachnic, et al.
Publicado: (2026)

Remnant cholesterol and systemic inflammation as synergistic predictors of cancer risk: A 16‐year prospective cohort study
por: Hongxue Xu, et al.
Publicado: (2025)

Adherens junction protein expression is associated with poor response to neoadjuvant FLOT chemotherapy and pro‐inflammatory tumor microenvironment in esophageal adenocarcinoma
por: Bastian Grothey, et al.
Publicado: (2026)

Influence of biologic sex and obesity on liver recurrence and survival in patients undergoing upfront surgery for pancreatic adenocarcinoma
por: Sean J. Judge, et al.
Publicado: (2025)

Deciphering the folate puzzle: Unraveling the impact of genetic variations and metabolites on cancer risk
por: Tong Liu, et al.
Publicado: (2024)

Association between TyG ‐related indices and colorectal cancer risk: A prospective cohort study
por: Runxue Jiang, et al.
Publicado: (2025)

Type‐ and age‐specific natural history of high‐risk human papillomavirus infections in healthy women: A prospective cohort study in China
por: Jiali Quan, et al.
Publicado: (2026)

Metabolism score and machine learning models for the prediction of esophageal squamous cell carcinoma progression
por: Lu Chen, et al.
Publicado: (2024)

Rectal adenocarcinoma: Ex vivo 9.4T MRI—correlation with histopathologic treatment response to neoadjuvant chemoradiotherapy
por: Zhihui Li, et al.
Publicado: (2024)

Post‐diagnostic multivitamin supplement use and colorectal cancer survival: A prospective cohort study
por: Ming‐ming He, et al.
Publicado: (2024)

Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
por: Guihong Liu, et al.
Publicado: (2024)

Radiotherapy and chemoradiotherapy for postoperative recurrence in patients with esophageal squamous cell carcinoma
por: Qing Liu, et al.
Publicado: (2024)

Survival outcome of esophagectomy and chemoradiotherapy for resectable esophageal squamous cell carcinoma in patients >75 years of age
por: Shuhei Mayanagi, et al.
Publicado: (2024)

Feasibility and accuracy of targeted axillary dissection by carbon tattooing in biopsy‐proven node‐positive breast cancer: A prospective study
por: Minyan Chen, et al.
Publicado: (2025)

Neoadjuvant chemoimmunotherapy was associated with better short‐term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy
por: Xiaofeng Duan, et al.
Publicado: (2024)

Hospital variation in treatment for synchronous metastatic esophageal and gastric cancer: A nationwide population‐based study in the Netherlands
por: Julie F. M. Geerts, et al.
Publicado: (2025)

Risk factors for suicide in patients with pancreatic ductal adenocarcinoma: A population‐based study
por: Chao Wang, et al.
Publicado: (2024)

Evolution of genome and immunogenome in esophageal squamous cell carcinomas driven by neoadjuvant chemoradiotherapy
por: Zelin Weng, et al.
Publicado: (2024)

Predisposing conditions in patients with small intestinal adenocarcinomas in the Netherlands: A 20‐year nationwide cohort study
por: Jasmijn D. G. Linssen, et al.
Publicado: (2025)

Active surveillance after neoadjuvant chemoradiotherapy for esophageal cancer
por: Mary Beth Nierengarten
Publicado: (2025)

Clinical relevance of somatic mutations in Chinese lung adenocarcinoma and their prognostic implications for survival
por: Tongxin Li, et al.
Publicado: (2024)

Dosimetric and clinical predictors for radiation esophagitis in patients with breast cancer undergoing conventional fractionated regional nodal irradiation: A prospective study
por: Dan‐Qiong Wang, et al.
Publicado: (2025)

New test for detecting cervical adenocarcinoma
Publicado: (2024)

Targeting the receptor tyrosine kinase MerTK shows therapeutic value in gastric adenocarcinoma
por: Naita Maren Wirsik, et al.
Publicado: (2024)

Poor oral health and the risk of esophageal squamous cell carcinoma in Malawi
por: Bongani Kaimila, et al.
Publicado: (2024)

A prospective single‐center, single‐arm, open‐label, phase II study of sintilimab and anlotinib combined with chemotherapy in neoadjuvant treatment of resectable esophageal cancer
por: Hongtao Duan, et al.
Publicado: (2024)

Reply to ‘Comment on “Plant‐based diet index and risk of hepatocellular carcinoma: Findings from a prospective cohort study”’
por: Yen Thi‐Hai Pham, et al.
Publicado: (2025)

Potential therapeutic effects of apigenin for colorectal adenocarcinoma: A systematic review and meta‐analysis
por: Koohyar Ahmadzadeh, et al.
Publicado: (2024)

Periostin is associated with prognosis and immune cell infiltration in pancreatic adenocarcinoma based on integrated bioinformatics analysis
por: Yijun Chen, et al.
Publicado: (2024)